Navigation Links
Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013

ip for Empatic on acceptable terms, if at all; and other risks described in Orexigen's filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and Orexigen undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof. Further information regarding these and other risks is included under the heading "Risk Factors" in Orexigen's Annual Report on Form 10-K filed with the Securities and Exchange Commission March 14, 2013 and its other reports, which are available from the SEC's website ( and on Orexigen's website ( under the heading "Investor Relations." All forward-looking statements are qualified in their entirety by this cautionary statement. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995. Orexigen Contact:

Media Contact:  McDavid Stilwell

Denise PowellVP, Corporate Communications and Business Development

BrewLife(858) 875-8629

(510) 703-9491 

Orexigen Therapeutics, Inc. Balance Sheets (In thousands, except share and par value amounts)June 30December 31,20132012(Unaudited)AssetsCurrent assets:Cash and cash equivalents 

78,332Investment securities, available-for-sale 

40,17859,071Prepaid expenses and other current assets 

2,9851,491Total current assets 

98,976138,894Property and equipment, net 

483Restricted cash 

177177Total assets 

39,154Liabilities and stockholders' equity Current liabilities:Accounts payable and accrued expenses 

8,156Accrued clinical trial expenses


SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
10. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
11. Orexigen Therapeutics to Present at Upcoming Investor Conferences
Post Your Comments:
(Date:10/9/2015)... 9, 2015  Hi-Tech Pharmaceuticals ("Hi-Tech"), a leading ... and iForce Nutrition ("iForce"), one of the fastest-growing Sports ... , today announced that they have entered ... agreed to acquire iForce. The transaction will enhance ... distribution through iForce,s strong distribution network. ...
(Date:10/9/2015)... 9, 2015 Eli Lilly and Company (NYSE: ... and approximately 50 new jobs to its research and development ... New York, New York . ... space will include a translational immuno-oncology hub and a Lilly ... collaborative access to cutting-edge drug discovery capabilities, including chemistry and ...
(Date:10/9/2015)... -- Ansun BioPharma announced a presentation at IDSA,s IDWeek ... the compassionate use of DAS181 under an emergency IND ... co-infected with influenza and parainfluenza (Abstract # 766 , ... requirement was reduced and the patient,s respiratory status ... the respirator on day 5. Between day 2 and ...
Breaking Medicine Technology:
... Perrigo Company (Nasdaq: PRGO ; TASE) today ... of $0.07 per share, payable on December 14, 2010 to ... dividend of $0.07 per share represents a twelve percent increase ... Perrigo Company is a leading global healthcare ...
... CITY, Calif, Oct. 27 Cardica, Inc. (Nasdaq: ... System and its PAS-Port® Proximal Anastomosis System will be ... the Advances in Robotic and Hybrid Coronary Revascularization conference, ... Robotic Surgery and Saint Joseph,s Hospital in Atlanta, Georgia. ...
Cached Medicine Technology:
(Date:10/9/2015)... Nedlands, WA, Australia (PRWEB) , ... October 09, ... ... be featured in an upcoming episode of Innovations with Ed Begley Jr., airing ... In this segment, Innovations will educate audiences on MMJ Phytotech Limited (MMJ) – ...
(Date:10/9/2015)... ... October 09, 2015 , ... Ryan ... and largest recreational dispensaries in Colorado, says the latest figures on the state’s ... and maturing into a legitimate industry. , Last month, according to ...
(Date:10/9/2015)... , ... October 09, 2015 , ... Most people assume ... with more vegetables and less meat. While noted T’ai Chi Master and integrative medicine ... and Yang” relationship between the two cuisines and that they potentially complement one another, ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... A variety of race options will be ... of Co-occurring Disorders on Sunday, October 18, at Al Lopez Park, 4810 North Himes Avenue, ... will include the choice of a 5K run or walk and a one-mile walk, followed ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... Kimberly Post, CPA , as Chief Financial Officer. Kimberly will provide ... and assist with any strategic acquisitions. Kimberly’s experience guiding healthcare services organizations ...
Breaking Medicine News(10 mins):
... SAN FRANCISCO, Sept. 23 Posit Science(R) CEO Steven Aldrich has been ... site for senior living, Inside Elder Care , based ... leadership, ideas and drive to make things better for a new generation ... fitness to consumers, said founder Ryan Malone who had a chance to ...
... , Sept. 27 Event to Benefit a National Nonprofit ... Sept. 23 To further its commitment to providing affordable options to couples ... Race for the Family on Sunday, September 27, at 8:30 ... ) , , More than 400 runners, walkers and toddler ...
... , SALT LAKE CITY, Sept. 23 Dynatronics Corporation (Nasdaq: ... and year ended June 30, 2009 during the morning of Friday, September ... third consecutive quarter of profitability. , , Dynatronics has ... ET to discuss its results for the quarter and year periods. ...
... , , , ... Aviva Family and Children,s Services , a non-profit, non-sectarian, ... and at-risk youth in the greater Los Angeles community, hosted a ... September 9, 2009. Los Angeles Mayor Antonio Villaraigosa and Supervisor ...
... success with their method, , WEDNESDAY, Sept. 23 (HealthDay ... to detect 80 percent of cases of postpartum depression, ... 10 women who give birth. , "Early diagnosis ... to intervene to prevent it from developing among women ...
... Foundation recently received a $1 million planned-gift donation ... radiology fellows to pursue this medical profession. SIR ... of interventional radiology by specializing in developing investigators ... research. "This enormously generous gift supports the ...
Cached Medicine News:
... advance of digital imaging technology, pathology ... digital formats, allowing for easier manipulation, ... in digital pathology imaging is analogous ... radiology, and which is continuing to ...
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
Each slide contains a gram positive control of Staphylococcus aureus ATCC ® 25923 and a gram negative control of Escherichia coli ATCC ® 25922....
Medicine Products: